跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irbepro - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Irbepro
Approved
STANDARD
Irbepro
Interphil Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5ed392feebd2220a
Company
Interphil Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
5ed392feebd2220a
Drug Approval Philippines Name
Irbepro
Product Name
Irbepro
Registration Number
DRP-3871-02
Brand Name
Irbepro
Generic Name
Irbesartan
Dosage Form
Tablet
Dosage Strength
300 mg
Manufacturer
Interphil Laboratories, Inc.
Distributor
Pascual Pharma Corporation
Issuance Date
24 May 2021
Expiry Date
16 May 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5ed392feebd2220a
Type
Standard
Back to Philippines FDA Approvals